Up to $1.5B on the Horizon for Alpine in four drug biobucks pact
Horizon Therapeutics will dole out up to $1.5 billion in milestone payments to bring up to four Alpine drugs from the horizon all the way to the top of the Alps.
Biotech Hub
Faculty Positions at Westlake Center for Genome Editing, Westlake University
Founded at Hangzhou, China in 2018, Westlake University is a private university, creating a stimulating, world-class environment for research and education in science, engineering and technology, and…
Pfizer joins $119M round for Novartis-backed cytokines biotech Anaveon to bankroll phase 2 studies
Pfizer and Novartis’ venture arms have joined investment firms in backing a $119 million series B for Anaveon. The Swiss biotech will deploy the proceeds on a phase 1/2 study in solid tumors.
Mystery no more: Mythic Therapeutics emerges with $103M to test antibody-drug conjugates in lung cancer
Mythic Therapeutics emerged with a $103 million series B to bankroll trials of its antibody-drug conjugates, which the small biotech claims are safer and smarter than previously developed treatments…
Tasso draws up $100M to advance at-home blood collection devices
Using push-button hardware that attaches to the upper arm, Tasso’s devices draw blood from capillaries through the skin, with no training necessary.
Glucose sensor developer Know Labs turns its AI toward a potential new moneymaker: NFTs
The company has latched onto the recent craze for trading nonfungible tokens, raising $4.2 million from sales of images that were algorithmically created using patterns driven by its deep learning…
Neogene adds ex-Roche director as CMO after snagging Bristol Myers, Arcellx vets
After snagging a 19-year Bristol Myers Squibb veteran in May and an Arcellx executive this fall, Neogene Therapeutics strikes again by poaching Gritstone Chief Medical Officer Raphaël Rousseau.
Precisely targeting liver cancer with logic-gated gene therapy
Borrowing a concept from computation, scientists at ETH Zurich created genetic ‘logic gates’ that can differentiate between tumor and nontumor cells based on their molecular profiles. A gene therapy…
Nurses in crisis over Covid dig in for better work conditions
Nurses and health care workers across the country are finding strength in numbers and with labor actions not seen in years. In California, which has a strong union tradition, Kaiser Permanente…
Eli Lilly joins Verge Genomics’ $98M round as AI-discovered ALS drug nears clinic
Three life science companies unveiled Series B rounds of funding Thursday, early Christmas gifts that top $219 million combined. Along with Verge Genomics, the other companies that raised new capital…